Idioma:

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update

Herlin, Morten Krogh ; Petersen, Michael Bjørn ; Brännström, Mats

Orphanet journal of rare diseases, 2020-08, Vol.15 (1), p.214-214, Article 214 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por

Enviar para

Título:
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update
Autor: Herlin, Morten Krogh ; Petersen, Michael Bjørn ; Brännström, Mats
Assuntos: 46, XX Disorders of Sex Development ; 46,XX DSD ; Adolescent ; Amenorrhea ; Aplasia ; Cervix ; Child ; Congenital Abnormalities ; Disorders of sex development ; Embryos ; Etiology ; Female ; Female genitalia ; Female infertility ; Females ; Fertility ; Genes ; Genetics ; Genomes ; Humans ; Hypotheses ; Infertility ; Karyotypes ; MRKH syndrome ; MRKHS ; Mullerian Ducts - abnormalities ; Müllerian aplasia ; Obstetrics, Gynecology and Reproductive Medicine ; Patients ; Reproduktionsmedicin och gynekologi ; Review ; Surgery ; Transplantation ; Uterus ; Uterus transplantation ; Vagina ; Vaginal agenesis ; XX DSD
É parte de: Orphanet journal of rare diseases, 2020-08, Vol.15 (1), p.214-214, Article 214
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
ObjectType-Review-1
Descrição: Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, also referred to as Müllerian aplasia, is a congenital disorder characterized by aplasia of the uterus and upper part of the vagina in females with normal secondary sex characteristics and a normal female karyotype (46,XX). The diagnosis is often made during adolescence following investigations for primary amenorrhea and has an estimated prevalence of 1 in 5000 live female births. MRKH syndrome is classified as type I (isolated uterovaginal aplasia) or type II (associated with extragenital manifestations). Extragenital anomalies typically include renal, skeletal, ear, or cardiac malformations. The etiology of MRKH syndrome still remains elusive, however increasing reports of familial clustering point towards genetic causes and the use of various genomic techniques has allowed the identification of promising recurrent genetic abnormalities in some patients. The psychosexual impact of having MRKH syndrome should not be underestimated and the clinical care foremost involves thorough counselling and support in careful dialogue with the patient. Vaginal agenesis therapy is available for mature patients following therapeutical counselling and education with non-invasive vaginal dilations recommended as first-line therapy or by surgery. MRKH syndrome involves absolute uterine factor infertility and until recently, the only option for the patients to achieve biological motherhood was through gestational surrogacy, which is prohibited in most countries. However, the successful clinical trial of uterus transplantation (UTx) by a Swedish team followed by the first live-birth in September, 2014 in Gothenburg, proofed the first available fertility treatment in MRKH syndrome and UTx is now being performed in other countries around the world allowing women with MRKH syndrome to carry their own child and achieve biological motherhood. Several advances in research across multiple disciplines have been made in the recent years and this kaleidoscopic review provides a current status of various key aspects in MRKH syndrome and provides perspectives for future research and improved clinical care.
Editor: England: BioMed Central
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update

Herlin, Morten Krogh ; Petersen, Michael Bjørn ; Brännström, Mats

England: BioMed Central

Buscando em bases de dados remotas. Favor aguardar.